HealthDay - Dr. Ashutosh K. Tewari: “Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study”

 – May 14, 2014  –– 

Hormone-depletion therapy is a common treatment for prostate cancer, but one that also carries side effects for men such as sexual dysfunction and fatigue. However, a new study suggests that in certain cases the treatment can be delayed – boosting the patient's quality of life. "In view of the cost and potential side effects that are associated with hormonal therapy, this is an important study that supports the notion that we don't have to jump on early hormonal therapy if PSA is showing signs of recurrence," said Ashutosh K. Tewari, MB, BS, Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. Learn more